Jeff Krasnoff | $100M+
THIS PROFILE WAS ADDED THROUGH THE AFFILIATE PROGRAM
Get in touch with Jeff Krasnoff | Jeff Krasnoff, founder and CEO of Rialto Capital Management, built a major real estate investment and asset management platform focused on distressed debt, commercial mortgages, and opportunistic property strategies. After launching Rialto in the aftermath of the financial crisis, Krasnoff helped grow the firm into a leading investor in complex real estate credit and special situations, working with institutional partners across the United States. Known for disciplined underwriting and large-scale capital deployment in dislocated markets, he has positioned Rialto as a significant player in commercial real estate finance.
Disclaimer: This profile is based on publicly available information. No endorsement or affiliation is implied.
Join UHNWI direct Affiliate Program
Earn Passive Income by Sharing Verified Contact Information of Billionaires, Centi-Millionaires, and Multi-Millionaires on the UHNWI Direct Platform
Maximize your earnings potential by sharing direct and validated contact information of the ultra-wealthy, including billionaires, centi-millionaires, and multi-millionaires. Join the UHNWI Direct platform and tap into a lucrative passive income stream by providing valuable data to those seeking high-net-worth connections. Start earning today with UHNWI Direct.
You may also be interested in reviewing other UHNWIs profiles.
To find the person you want to contact, start typing their name or other relevant tags in the search bar.
Please note: Our database contains over 10,000 direct contacts of UHNWIs, and it is highly likely that the individual you are seeking is already included. However, creating individual profiles for each contact is a meticulous and time-intensive process, So, if you are unable to find the profile of the individual you are looking for, please click here.
Filter by Net Worth: All | Billionaires | Centi-Millionaires | Multi-Millionaires
Filter by Location: All | USA | Canada | Europe | UK | Russia & CIS | Asia | MEIA | Australia | Latin America
Filter by Age: 1920-1930 | 1930-1940 | 1940-1950 | 1950-1960 | 1960-1970 | 1970-1980 | 1980-1990 | 1990-2000
Related People
Edward DeBartolo Jr., former owner of the San Francisco 49ers and heir to a shopping center fortune, built a rare legacy spanning both real estate wealth and sports dominance. Best known for overseeing the 49ers’ dynasty years, during which the franchise won five Super Bowls, he also remained tied to one of America’s most prominent mall-developing families. Though later overshadowed by legal controversy, DeBartolo endures as one of the most consequential figures in modern NFL ownership.
Robert Steers, cofounder and executive chairman of Cohen & Steers, helped build one of the first investment firms dedicated to listed real estate securities and turn it into a major force in real assets and income investing. He launched the firm with Martin Cohen in 1986, helped take it public in 2004, and spent decades shaping its expansion from a REIT-focused specialist into a broader asset manager with a global footprint. Known for long-term conviction and deep expertise in real estate securities, Steers remains one of the defining figures in modern real-assets investing.
Herriot Tabuteau, founder, CEO, and chairman of Axsome Therapeutics, has built one of biotech’s most closely watched companies by focusing on treatments for central nervous system disorders. A Yale-trained physician with a background in healthcare investing, he launched Axsome in 2012 and helped turn it into a major player in depression, Alzheimer’s agitation, and other brain-health markets. Known for combining scientific ambition with financial discipline, Tabuteau has emerged as one of the most notable entrepreneurs in modern neuropsychiatric drug development.
David Adelman, CEO of Campus Apartments, turned an early teenage investment in student housing into one of the country’s leading privately held college-living platforms. Based in Philadelphia, he helped grow the business into a multibillion-dollar real estate company with assets under management across numerous states, while also expanding his reach into private investing, sports ownership, and finance. Known for aggressive dealmaking and institutional capital instincts, Adelman has become one of the most prominent entrepreneurs in student housing and adjacent real estate.
Michael Dorrell, chairman, CEO, and cofounder of Stonepeak, built the firm into one of the most influential investors in infrastructure and real assets. Since founding Stonepeak in 2011, he has helped turn it into a global private-markets powerhouse spanning energy, transport, digital infrastructure, and logistics. Known for disciplined dealmaking and long-horizon conviction, Dorrell has emerged as one of the standout billionaires created by the modern infrastructure investing boom.
Fernando De Leon, founder and CEO of Leon Capital Group, built a Dallas-based holding company that spans real estate, healthcare, financial services, and technology. After starting in real estate, he expanded aggressively across sectors, helping turn Leon into a multibillion-dollar platform with a reputation for opportunistic investing and long-term ownership. Known for combining entrepreneurial range with disciplined dealmaking, De Leon has emerged as one of the most prominent self-made billionaires in Texas business.
Arnold Schwarzenegger, actor, businessman, and former California governor, turned global fame in bodybuilding and Hollywood into a billion-dollar brand spanning entertainment, real estate, and investments. After rising from Austrian bodybuilder to blockbuster star through franchises like Terminator, he expanded his influence into politics and entrepreneurship, building one of the most recognizable personal empires in modern celebrity culture. He remains a rare figure whose success spans sport, film, business, and public life.
Stuart Miller, executive chairman and co-CEO of Lennar, has spent more than four decades helping build the company into one of America’s largest homebuilders. The son of early Lennar investor Leonard Miller, he led the firm through major expansion cycles and helped shape its evolution beyond homebuilding into financial and real estate-related services. Known for long-term strategic control and deep influence over the business, Miller remains one of the most prominent figures in U.S. residential real estate.
Vivek Ramaswamy, biotech entrepreneur, investor, and political figure, founded Roivant Sciences and built his fortune by acquiring and developing overlooked drug assets through a distinctive biotech platform. He later cofounded Strive Asset Management and gained national prominence during his 2024 presidential bid, extending his influence from finance and healthcare into public life. Known for his sharp rhetoric, high-risk conviction, and outsider brand, Ramaswamy has emerged as one of the most visible figures linking biotech wealth, capital markets, and conservative politics.
Mitchell Morgan, founder and chairman of Morgan Properties, built one of the largest private apartment empires in the United States by focusing on older multifamily assets in secondary markets and scaling them through disciplined acquisitions and renovation. Since founding the company in 1985, he has grown Morgan Properties into a portfolio of more than 350 communities and roughly 100,000 units, making it one of the country’s biggest multifamily owners. In 2026, Morgan stepped down as CEO and passed day-to-day leadership to his sons, while remaining chairman of the business he built.
William C. Rudin, co-executive chairman of Rudin Management, leads one of New York City’s most prominent real estate families, overseeing a major portfolio of office and residential properties across Manhattan. As a third-generation leader of the privately held firm founded in the 1920s, Rudin has guided the development and modernization of landmark buildings while expanding the company’s presence in commercial real estate and urban development. Known for long-term ownership and deep ties to New York’s civic and business institutions, he remains a central figure in the city’s real estate landscape.
Jeff Krasnoff, cofounder and managing principal of Rialto Capital Management, built a major real estate investment and asset management platform focused on distressed debt, commercial mortgages, and opportunistic property strategies. After launching Rialto in the aftermath of the financial crisis, Krasnoff helped grow the firm into a leading investor in complex real estate credit and special situations, working with institutional partners across the United States. Known for disciplined underwriting and large-scale capital deployment in dislocated markets, he has positioned Rialto as a significant player in commercial real estate finance.
Wayne Hughes Jr., chairman of Public Storage, oversees one of the largest self-storage empires in the world, continuing the legacy built by his father, company founder Wayne Hughes. After years in private investing and philanthropy, he assumed a leading role in the publicly traded REIT, guiding strategy across a vast portfolio of storage properties throughout the United States and Europe. Known for low-profile leadership and long-term ownership discipline, Hughes represents a new generation of stewardship within one of the most profitable real estate business models in modern property investing.
Alan Smolinisky is a billionaire entrepreneur, principal at Conquest Housing, and co-owner of the Los Angeles Dodgers. He first built his fortune with Conquest Student Housing, which became the largest provider at USC before selling for $205 million in 2008. In 2026, he serves as a director at Jack in the Box, chairing its Capital Allocation Committee following a late 2025 appointment. A dedicated value investor and philanthropist, he has committed 90% of his estate to charity and is a vocal advocate for immigration reform, famously hosting mass naturalization ceremonies at Dodger Stadium. He remains a key figure in sports business, previously partnering with Phil Knight on a $2 billion bid for the Portland Trail Blazers.
Thomas Barrack Jr. is the U.S. Ambassador to Türkiye and the Special Envoy for Syria in the second Trump administration, where he serves as a pivotal figure in Middle Eastern diplomacy. A veteran private equity investor and the founder of Colony Capital (now DigitalBridge), Barrack has leveraged his decades of experience in the region to broker historic regional agreements. In early 2026, he played a lead role in integrating the Syrian government into the Global Coalition to Defeat ISIS and oversaw major infrastructure MoUs, including a milestone gas exploration agreement between Syria and Chevron. His current diplomatic portfolio emphasizes regional security through "shared responsibility," successfully managing the complex transition of territory between the Syrian Democratic Forces and the central government in Damascus.
Stewart Rahr is the billionaire founder of Kinray, which he grew into the largest privately held pharmaceutical distributor in the world before its $1.3 billion sale to Cardinal Health in 2010. Known as the self-styled "Number One King of All Fun," Rahr is a permanent fixture in New York’s high-society and philanthropic circles. His Stewart J. Rahr Foundation has donated over $25 million to the Make-A-Wish Foundation alone, alongside significant contributions to cancer and medical research. A flamboyant figure with a reputation for grand charity galas and celebrity connections, he remains a central force in American philanthropy and land stewardship in the Hamptons.
Steven Klinsky is the founder and CEO of New Mountain Capital, a private equity firm that manages over $50 billion in assets and focuses on high-growth, non-cyclical businesses. Before founding his firm in 1999, he was a pioneer in the industry at Goldman Sachs and a general partner at Forstmann Little, where he helped develop the strategy of business-building over financial engineering. Klinsky is also a major figure in education reform, having established the Modern States Education Alliance, which provides free college-level courses and credit to hundreds of thousands of students globally.
Stephane Bancel is the CEO of Moderna, the biotechnology firm that gained global prominence for its pioneering use of messenger RNA (mRNA) technology. Since taking the helm in 2011, Bancel transitioned the company from a pre-clinical startup into a commercial powerhouse, most notably leading the rapid development and global distribution of one of the first COVID-19 vaccines. His leadership is characterized by an aggressive "platform" approach to drug development, aiming to treat everything from rare genetic diseases to cancer and respiratory viruses by turning human cells into drug factories. Under his tenure, Moderna has become a symbol of the genomic revolution, reshaping the pharmaceutical industry’s traditional R&D timelines.
Robert Duggan, biotech entrepreneur and investor, built his fortune by identifying overlooked medical assets and scaling them into blockbuster businesses. He is best known for leading Pharmacyclics as CEO and majority owner, turning the company into a major oncology success through the development of Imbruvica, before selling it to AbbVie in a multibillion-dollar deal. Known for bold conviction, aggressive capital deployment, and a willingness to bet heavily on scientific outcomes, Duggan has become one of the most successful dealmakers in modern biotechnology.
Richard Peery, founder of the Peery family real estate enterprise, built one of Silicon Valley’s most influential commercial property portfolios by specializing in high-quality office and industrial developments in Northern California. Known for acquiring and developing strategic assets near the world’s leading technology corridors, Peery helped shape the physical infrastructure that supported the region’s growth for decades. Operating with a low public profile, he expanded through long-term ownership, disciplined management, and a deep understanding of location-driven value. Peery is also recognized for philanthropy supporting education, community development, and civic initiatives.
Richard LeFrak, chairman and CEO of LeFrak Organization, leads one of America’s most enduring real estate dynasties, overseeing a vast portfolio of residential, commercial, and mixed-use assets. Building on the legacy of his father Samuel LeFrak, he expanded the family’s holdings across New York, New Jersey, and Florida, including landmark developments such as Newport in Jersey City. Known for long-term ownership, disciplined capital deployment, and large-scale urban development, LeFrak has shaped major waterfront and city-center projects while maintaining the firm as a privately held powerhouse.
Richard Kurtz, founder and chairman of Kamson Corporation, built a major privately held real estate company specializing in multifamily and mixed-use properties across the Northeastern United States. Starting with a focus on apartment ownership and management, Kurtz grew Kamson through disciplined acquisitions, property repositioning, and long-term operational control, creating a large portfolio spanning residential communities and commercial assets. Known for quiet execution and a patient, cash-flow-driven strategy, he has maintained Kamson as a durable family-led platform through multiple real estate cycles.
Raymond J. Harbert, founder and CEO of Harbert Management Corporation, built a major alternative investment platform spanning private equity, real estate, infrastructure, and credit. After starting his career in banking and leveraged finance, Harbert founded his firm in 1993 and grew it into a global manager serving institutions and high-net-worth investors with long-term, diversified strategies. Known for disciplined capital allocation and a conservative, steady approach across market cycles, Harbert has also become a prominent philanthropist supporting education, medical research, and civic initiatives, particularly in the American South.
Randal J. Kirk, biotech entrepreneur and investor, built his fortune by creating and scaling life-sciences companies focused on drug development, specialty pharmaceuticals, and healthcare innovation. Best known as the founder of Intrexon and as the driving force behind multiple public biotech ventures, Kirk has pursued an aggressive strategy of acquiring scientific platforms, recruiting top research talent, and commercializing high-value therapies. His long-term influence spans pharmaceuticals, genetics, and medical technology, reflecting a rare ability to combine capital markets skill with scientific ambition.
Purnendu Chatterjee, founder and chairman of The Chatterjee Group, built a diversified global investment firm by taking concentrated, long-term positions in industrial, chemical, consumer, and infrastructure businesses. A former partner at Soros Fund Management, Chatterjee applies activist discipline and operational focus to complex situations, often partnering closely with management to drive strategic change. His portfolio has included significant stakes across the U.S., Europe, and Asia, reflecting a patient, hands-on approach to value creation.
Phillip Frost, physician and entrepreneur, built a biotechnology empire by identifying undervalued medical assets and scaling them through disciplined science-driven investing. As founder and chairman of OPKO Health, Frost assembled a diversified healthcare platform spanning diagnostics, pharmaceuticals, and medical technologies, often through strategic acquisitions and partnerships. Earlier in his career, he sold IVAX Corporation to Teva in a multibillion-dollar transaction, cementing his reputation as a leading dealmaker in life sciences. Known for a long-term approach to innovation and capital allocation, Frost remains a central figure in global healthcare entrepreneurship.
Philip Milstein, founder and CEO of Ogden CAP Properties, built a major New York–based real estate investment platform focused on value-oriented acquisitions across office, residential, and mixed-use properties. After early experience in property development and asset management, Milstein expanded Ogden CAP by targeting complex, underperforming assets and repositioning them through active management and long-term capital discipline. Known for a hands-on approach and deep market knowledge, he has assembled a sizable portfolio while maintaining a low public profile. Milstein’s career reflects patient investing and contrarian thinking within urban real estate markets.
Peter Thiel, cofounder of PayPal and Palantir Technologies, is one of Silicon Valley’s most influential and contrarian thinkers, known for backing companies that challenge consensus and reshape entire industries. As an early investor in Facebook and the first outside investor in several category-defining startups, Thiel helped popularize a philosophy centered on building monopolies through deep technology rather than incremental competition. Through Founders Fund, he has backed transformative ventures across software, defense, biotech, and space. Thiel’s impact extends beyond investing into ideas, shaping debates around technology, globalization, and the future of innovation.
Peter Gassner, cofounder and CEO of Veeva Systems, built one of the most successful vertical software companies by focusing exclusively on cloud solutions for the life sciences industry. After an early career at Salesforce, where he helped scale enterprise cloud adoption, Gassner launched Veeva in 2007 to serve pharmaceutical and biotech companies with regulated, mission-critical applications. Under his leadership, Veeva became a publicly traded, highly profitable software company known for deep industry specialization, long-term customer relationships, and disciplined execution. Gassner’s approach exemplifies the power of focus and vertical expertise in enterprise software.
Patrick Soon-Shiong, physician, biotech entrepreneur, and investor, built one of the most consequential careers at the intersection of medicine, science, and capital. After developing the cancer drug Abraxane, which he sold to Celgene in a multibillion-dollar deal, Soon-Shiong went on to found and back numerous life-sciences companies focused on immunotherapy, data-driven medicine, and personalized healthcare. Beyond biotech, he is the owner of the Los Angeles Times and has invested heavily in medical research, AI-enabled health systems, and pandemic preparedness. His work reflects a long-term ambition to reengineer healthcare around biology, data, and scalable innovation.
